/BMRN

BioMarin Pharmaceutical Inc

BMRN

$65.68USD↑+0.26%+0.17 today

MARKET CAP

12.7B

P/E (TTM)

47.9x

FWD P/E

—

DAY RANGE

$65 – $66

52W RANGE

$49

$71

AI Summary

Stalk

StalkMedium

BMRN is consolidating within its Stage 2 advance after a blow-off peak, maintaining a medium-term bullish bias above the rising 50-day and 200-day SMAs. Short-term momentum is neutral with 9- and 20-day EMAs flat and RSI near mid-range, offering no immediate entry edge. A pullback to the 50-day SMA (around $63) or the lower end of the recent $64–$68 range would provide a lower-risk opportunity. Stalk for a test of support before initiating longs.

↑Q2 2026 revenue $989.7M (+20% YoY), non-GAAP operating margin 36.4%.
↑Raises full-year 2026 sales guidance to $3.88–$3.93B on strong product demand.
↓Acquisition financing adds ~$200M annual interest expense, pressuring earnings.

Full analysis →

Buying

9

institutions

Selling

9

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	20.45 M	1.17 B	+626.91 K	+4.5%	0.02%
VG Viking Global Investors LP Q2 2026	BUY	7.62 M	435.82 M	+554.49 K	+9.3%	1.24%
AC Aqr Capital Management LLC Q2 2026	SELL	5.70 M	322.54 M	+-1.98 M	-24.9%	0.11%
MM Millennium Management LLC Q2 2026	SELL	2.11 M	120.95 M	+-954.49 K	-30.2%	0.04%
JH Janus Henderson Group Plc Q1 2026	BUY	1.71 M	96.82 M	+1.44 M	+489.5%	0.02%
CA Citadel Advisors LLC Q2 2026	SELL	1.40 M	80.28 M	+-3.29 M	-69.8%	0.01%
BA Balyasny Asset Management L.P. Q2 2026	SELL	1.05 M	60.34 M	+-308.14 K	-21.6%	0.08%
JC Jpmorgan Chase & Co Q2 2026	BUY	694.55 K	40.57 M	+136.71 K	+32.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	451.87 K	25.86 M	+-573.00 K	-55.3%	0.04%
CP California Public Employees Retirement System Q2 2026	SELL	439.09 K	25.12 M	+-51.62 K	-9.4%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	433.38 K	24.80 M	+61.18 K	+17.9%	0.04%
MG Man Group Plc Q2 2026	BUY	367.98 K	21.06 M	+58.32 K	+20.4%	0.03%
BA Bridgewater Associates, LP Q2 2026	BUY	274.91 K	15.73 M	+68.00 K	+34.6%	0.06%
EP Eversept Partners, LP Q2 2026	BUY	249.61 K	14.28 M	+41.84 K	+21.7%	0.74%
AC Adar1 Capital Management, LLC Q2 2026	BUY	49.00 K	2.80 M	+30.80 K	+172.7%	0.13%
FA Fisher Asset Management, LLC Q2 2026	SELL	35.39 K	2.02 M	+-91.00	+1.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-1.30 M	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-9.95 K	-100.0%	0.00%